Clinical Trial Update: Haploidentical Hematopoietic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial update reports the completion of a haploidentical hematopoietic stem cell transplantation study led by Catherine Bollard, investigating treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Snippet

Sponsor: Catherine Bollard | Conditions: Sickle Cell-thalassemia Disease, Thalassemia | Phase 1 | Status: COMPLETED